Most Cited Antibody in 2014


Anti-Histone H3 antibody (Abcam)

This award recognises Abcam’s Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade as the individual antibody that has been cited in peer reviewed academic literature the highest number of times during 2014. The antibody has a total of 858 citations in the CiteAb database and added well over 100 in 2014.

From the data generated through CiteAb we are able to gain a really clear picture of the way antibodies are used around the world. We can tell which countries are investing most in research using antibodies, which companies are seeing growth or decline, which antibodies are most successful and which areas of research are seeing growth.

Abcam’s Anti-Histone H3 antibody was established as the winner of this award based on CiteAb citation data from the January - December 2014 period showing that this individual antibody had the highest number of citations in that period.

Dr Andrew Chalmers, founder of CiteAb, said: “Looking at the data for this award, it has been really interesting to see which antibodies are most frequently used by scientists. Loading controls - like this antibody and first runner up - and anti-tag antibodies like the second runner up are used in almost every laboratory.

"Cambridge, UK-based Abcam have really demonstrated strength over the past year. We’re all excited to see where the company heads in 2015."

The catalogue code for this antibody is ab1791.

RUNNER UP: Monoclonal Anti-Beta-Actin [AC-15] from Sigma-Aldrich

Sigma-Aldrich’s Monoclonal Anti-Beta-Actin [AC-15] antibody is runner up in this category with 436 citations, 112 of which were added in 2014.

The catalogue code for this antibody is A1978.

RUNNER UP: Anti-GFP antibody from Abcam

Abcam are in both first and third place for this award. The company’s Anti-GFP antibody has 345 citations on CiteAb, 80 of which were added in 2014.

The catalogue code for this antibody is Ab290.

Back To Categories